Quinapril blood pressure tablets recalled over potential cancer risk

Four lots of the blood pressure medication Quinapril were voluntarily recalled last week by drug manufacturer Lupin Pharmaceuticals Inc. over concerns it could increase the risk of cancer, according to the Food and Drug Administration.Lupin Pharmaceuticals Inc.’s Quinapril tablets, sold in 20 mg and 40 mg, may contain an elevated level of nitrosamine impurity, N-Nitroso-Quinapril, above the acceptable daily intake level. Nitrosamine impurities are common in consumables, including cured and grilled meats, vegetables and dairy products, according to the recall.“Everyone is exposed to some level of nitrosamines,” the recall states. “ These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time.”What else is under recall?:Check out USA TODAY’s searchable recall databasePatients who are on the medication don’t need to stop taking it immediately, but are advised to discuss an alternative treatment with their healthcare provider.

Source: Quinapril blood pressure tablets recalled over potential cancer risk